Showing 2,406 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Money

Kenya families facing HIV and high food prices make tough choices on who gets fed

Editor's pick
Washington Post
22 December 2011
How HIV works

Pathogenic Landscape of HIV

Editor's pick
UCSF Today
21 December 2011
New & experimental HIV treatments

Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Gilead press release
21 December 2011
Pharmaceutical industry

Gilead's New HIV Drug Pipeline: What You Need To Know For 2012

Editor's pick
Seeking Alpha
20 December 2011
Clinical trials

Letter Opposing a Proposed Low-dose Stavudine Trial

Editor's pick
Treatment Action Group
20 December 2011
New & experimental HIV treatments

Testing nasal vaccine for HIV treatment

Editor's pick
Health Canal
19 December 2011
Starting treatment

New Roche Screening Test for Abacavir Hypersensitivity Available in Europe

Editor's pick
AEGiS
19 December 2011
Starting treatment

Immediate ART during Early HIV Infection May Delay Disease Progression

Editor's pick
HIVandHepatitis.com
19 December 2011
New & experimental HIV treatments

Novel HIV-Associated Diarrhea Drug Crofelemer Goes to FDA for Approval Review

Editor's pick
AIDSMeds.com
15 December 2011
New & experimental HIV treatments

Aethlon Medical Announces HIV-AIDS Research Discovery

Editor's pick
PR Newswire (press release)
15 December 2011
Side effects

Salix submits FDA application for Crofelemer for the Treatment of HIV-Associated Diarrhea

Editor's pick
CNBC
14 December 2011
Adherence

In Combatting AIDS, Beware Methods That Depend on Human Discipline

Editor's pick
Bloomberg (editorial)
14 December 2011
Health problems & ageing

ICASA 2011: World Health Organization releases first treatment guidelines for HIV and meningitis

Editor's pick
Key Correspondents
9 December 2011
New & experimental HIV treatments

Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir

Editor's pick
Market Watch
9 December 2011
TB transmission & prevention

CDC releases new 12-dose treatment guidelines for latent TB infection

Editor's pick
Science Speaks
8 December 2011
Side effects

HIV-Associated Neuropathy Is More Common In African-American Women

Editor's pick
The AIDS Beacon
8 December 2011
Pharmaceutical industry

Theratechnologies to discontinue COPD clinical program and focus on lipodystrophy

Editor's pick
Theratechnologies press release
8 December 2011
PrEP

UCLA researchers suggest unconventional approach to control HIV epidemics

Editor's pick
Eurekalert Medicine & Health
7 December 2011
Bad science & bogus treatments

UK: 'HIV Healing' Church Will Not Be Punished

Editor's pick
Sky News
6 December 2011
New & experimental HIV treatments

Boosting Agent Cobicistat Comparable to Norvir in Phase III Study

Editor's pick
AIDSMeds
6 December 2011
Pharmaceutical industry

Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies

Editor's pick
Motley Fool
5 December 2011
New & experimental HIV treatments

Europe approves Gilead's HIV combo Eviplera

Editor's pick
Pharma Times
5 December 2011
Resistance

Microsoft Research: Spammers Act Just Like HIV Virus In Avoiding Filters

Editor's pick
ThreatPost.com
3 December 2011
Starting treatment

Acute infection: when to start treatment?

Editor's pick
Wellcome Trust
2 December 2011